Picture of Repligen logo

RGEN — Repligen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Repligen Corp expected to post earnings of 30 cents a share - Earnings Preview

* Repligen Corp  RGEN.OQ   RGEN.O  is expected to show a
fall in
quarterly revenue when it reports  results on May 1 for the
period ending March 31 2024
    * The Waltham Massachusetts-based  company is expected to
report a
17.8% decrease in revenue to $150.062 million from $182.66
million a year ago, according to the mean estimate from 12
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Repligen Corp is for
earnings
of 30 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Repligen
Corp is
$215.00​, above​ its last closing price of $166.58. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  0.33        0.33       0.33      Met     1.4
 Sep. 30 2023  0.17        0.17       0.23      Beat    38.7
 Jun. 30 2023  0.48        0.48       0.53      Beat    11.5​
 Mar. 31 2023  0.59        0.59       0.64      Beat    9
 ​​Dec.        0.57        0.58       0.68      Beat    17.8
 31 2022                                                
 Sep. 30 2022  0.68        0.68       0.77      Beat    13.2​
 Jun. 30 2022  0.72        0.72       0.91      Beat    27
 Mar. 31 2022  0.72        0.72       0.92      Beat    27.8
 This summary was machine generated April 29 at 15:33 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Repligen

See all news